These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27046239)

  • 1. Norovirus Infection: Replication, Manipulation of Host, and Interaction with the Host Immune Response.
    Sarvestani ST; Cotton B; Fritzlar S; O'Donnell TB; Mackenzie JM
    J Interferon Cytokine Res; 2016 Apr; 36(4):215-25. PubMed ID: 27046239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norovirus.
    Robilotti E; Deresinski S; Pinsky BA
    Clin Microbiol Rev; 2015 Jan; 28(1):134-64. PubMed ID: 25567225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norovirus immunology: Of mice and mechanisms.
    Newman KL; Leon JS
    Eur J Immunol; 2015 Oct; 45(10):2742-57. PubMed ID: 26256101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norovirus Regulation by Host and Microbe.
    Baldridge MT; Turula H; Wobus CE
    Trends Mol Med; 2016 Dec; 22(12):1047-1059. PubMed ID: 27887808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noroviruses: epidemiology, immunity and prospects for prevention.
    Pringle K; Lopman B; Vega E; Vinje J; Parashar UD; Hall AJ
    Future Microbiol; 2015; 10(1):53-67. PubMed ID: 25598337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Norovirus infections: an overview].
    de Rougemont A; Ambert-Balay K; Belliot G; Pothier P
    Med Sci (Paris); 2010 Jan; 26(1):73-8. PubMed ID: 20132778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype.
    Tamminen K; Huhti L; Vesikari T; Blazevic V
    Viral Immunol; 2013 Apr; 26(2):167-70. PubMed ID: 23438469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norovirus vaccines under development.
    Lucero Y; Vidal R; O'Ryan G M
    Vaccine; 2018 Aug; 36(36):5435-5441. PubMed ID: 28668568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
    Lindesmith LC; Ferris MT; Mullan CW; Ferreira J; Debbink K; Swanstrom J; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS
    PLoS Med; 2015 Mar; 12(3):e1001807. PubMed ID: 25803642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human norovirus infection and the acute serum cytokine response.
    Newman KL; Moe CL; Kirby AE; Flanders WD; Parkos CA; Leon JS
    Clin Exp Immunol; 2015 Nov; 182(2):195-203. PubMed ID: 26178578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norovirus vaccines: Correlates of protection, challenges and limitations.
    Melhem NM
    Hum Vaccin Immunother; 2016 Jul; 12(7):1653-69. PubMed ID: 26836766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in norovirus biology.
    Karst SM; Wobus CE; Goodfellow IG; Green KY; Virgin HW
    Cell Host Microbe; 2014 Jun; 15(6):668-80. PubMed ID: 24922570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norovirus mechanisms of immune antagonism.
    Roth AN; Karst SM
    Curr Opin Virol; 2016 Feb; 16():24-30. PubMed ID: 26673810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDA-5 recognition of a murine norovirus.
    McCartney SA; Thackray LB; Gitlin L; Gilfillan S; Virgin HW; Colonna M
    PLoS Pathog; 2008 Jul; 4(7):e1000108. PubMed ID: 18636103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of Norovirus GII.4 variants in acute gastroenteritis outbreaks in South Korea between 2006 and 2013.
    Cho HG; Park PH; Lee SG; Kim JE; Kim KA; Lee HK; Park EM; Park MK; Jung SY; Lee DY; Yoon MH; Lee JB; Paik SY
    J Clin Virol; 2015 Nov; 72():11-5. PubMed ID: 26356986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of immunity to norovirus gastroenteritis.
    Simmons K; Gambhir M; Leon J; Lopman B
    Emerg Infect Dis; 2013 Aug; 19(8):1260-7. PubMed ID: 23876612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemic and control strategy on nosocomial outbreak of norovirus gastroenteritis].
    Xu Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Oct; 30(5):614-7. PubMed ID: 19024398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the homo- and heterotypic immune responses after natural norovirus infection.
    Rockx B; Baric RS; de Grijs I; Duizer E; Koopmans MP
    J Med Virol; 2005 Nov; 77(3):439-46. PubMed ID: 16173019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular chaperone Hsp90 is a therapeutic target for noroviruses.
    Vashist S; Urena L; Gonzalez-Hernandez MB; Choi J; de Rougemont A; Rocha-Pereira J; Neyts J; Hwang S; Wobus CE; Goodfellow I
    J Virol; 2015 Jun; 89(12):6352-63. PubMed ID: 25855731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Antinorovirus Genes in Human Cells Using Genome-Wide CRISPR Activation Screening.
    Orchard RC; Sullender ME; Dunlap BF; Balce DR; Doench JG; Virgin HW
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30305350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.